Adyghe Int. Sci. J. Vol. 25, No. 3. Pp. 55–61.
Read article Contents of this issue
DOI: https://doi.org/10.47928/1726-9946-2025-25-3-55-61
EDN: IKAMGC
MEDICINE
| UDC 616.65-002 | Original Article |
Impact of a course of normobaric hypoxic training
on subjective well-being indicators in patients diagnosed with chronic prostatitis
Murat Khasanovich Makhov
MD, PhD, urologist, associate professor of the department of faculty and endoscopic surgery of Kabardino-Balkarian State University named after Kh. M. Berbekov, (360004, KBR, Nalchik, Chernyshevsky str., 173), ORCID: https://orcid.org/0000-0003-2747-3898, mahov_murat@mail.ru
Abstract. Hypoxic therapy is poorly studied in urology. The study aimed to substantiate the use of interval normobaric hypoxic training to correct psychophysiological disorders in patients with chronic prostatitis. 36 men with chronic prostatitis were randomized into 3 groups: 1. Hypoxia-Normoxia (n=12): standard drug therapy + 10 sessions with 13 % O2. 2. Hypoxia-Hyperoxia (n=12): standard therapy + 10 sessions with 31 % O2. 3. Control (n=12): pharmacotherapy only. Asthenic symptoms were assessed using a questionnaire before and during sessions. The most significant positive dynamics were in the Hypoxia-Hyperoxia group: the number of complaints decreased 3 times, and their intensity more than doubled. The Hypoxia-Normoxia group showed less improvement: the number of complaints decreased less than 2 times, and their severity by 20 %. No significant dynamics were found in the control group. Interval hypoxic training, especially the “hypoxia-hyperoxia” scheme, is effective in reducing asthenic syndrome and can be recommended as an adjuvant therapy to improve patients’ quality of life. The method is promising for further research.
Keywords: normobaric hypoxic therapy, hypoxic training, chronic prostatitis, asthenic syndrome, hyperoxia.
Funding. The work was not carried out within the framework of funds.
Competing interests. There are no conflicts of interest regarding authorship and publication.
Contribution and Responsibility. The author participated in the writing of the article and is fully responsible for submitting the final version of the article to the press.
For citation. Makhov M. Kh. Impact of a course of normobaric hypoxic training on subjective wellbeing indicators in patients diagnosed with chronic prostatitis. Adyghe Int. Sci. J. 2025. Vol. 25, No. 3. Pp. 55–61.
DOI: https://doi.org/10.47928/1726-9946-2025-25-3-55-61; EDN: IKAMGC
Submitted 16.08.2025; approved after reviewing 25.08.2025; accepted for publication 28.08.2025.
© Makhov M. Kh., 2025
REFERENCES
1. Kolchinskaya A. Z. Interval hypoxic training – efficiency, mechanisms of action. M.: Kyiv, 1992. 159 p.
2. Borukaeva I. Kh., Tsyganova T. N. Combined use of hypoxic therapy and oxygen therapy in spa treatment of bronchial asthma// Issues of balneology, physiotherapy and therapeutic physical culture. 2012, No. 4. Pp. 10–14.
3. Evaluation of the direct impact of normobaric interval hypoxic training on the subjective state of patients with chronic prostatitis / I. A. Miziev, M. Kh. Makhov, Zh. Kh. Sabanchieva [et al.] // Chief Physician of the South of Russia. 2025. No. 2 (100). Pp. 44–48. EDN CRUHNH
4. Konchugova T. V., Orekhova E. M., Kulchitskaya D. B. Main achievements and directions of development of hardware physiotherapy// Issues of balneology, physiotherapy and therapeutic physical culture. 2013. No. 1. Pp. 26–31.
5. Tsyganova T. N. Efficiency of interval hypoxic training in sports (review article) // Exercise therapy and sports medicine. 2015. No. 6. Pp. 47–54.
6. Ichihara K., Takahashi S., Hiyama Y., Masumori N., Nagae H., Ito S., Wada K., Betsunoh H., Hamasuna R., Togo Y., Shigemura K., Takeyama K. Distribution of the positive UPOINT domain in patients with chronic prostatitis or chronic pelvic pain syndrome: A multicenter observational study. J Infect Chemother. 2022. May; 28(5): 631–634. Doi: 10.1016/j.jiac.2022.01.005. Epub 2022. Jan 31. PMID: 35101387
7. Bryk D. J, Shoskes D. A. Using the UPOINT system to manage men with chronic pelvic pain syndrome. Arab J. Urol. 2021. Jul 23; 19(3): 387–393. Doi: 10.1080/2090598X.2021.1955546. PMID: 34552790; PMCID: PMC8451687
8. Magistro G., Wagenlehner F. M. E., Pilatz A. Chronische prostatitis/chronisches beckenschmerzsyndrom [Chronic prostatitis/chronic pelvic pain syndrome]. Urologie. 2023. Jun; 62(6): 590–596. German. Doi: 10.1007/s00120-023-02089-2. Epub 2023. Apr 30. PMID: 37120786
9. Maeda K., Shigemura K., Fujisawa M. A review of current treatments for chronic prostatitis/chronic pelvic pain syndrome under the UPOINTS system. Int. J. Urol. 2023. May; 30(5): 431–436. Doi: 10.1111/iju.15149. Epub 2023. Feb 14. PMID: 36788717
10. Stamatiou K., Trinchieri M., Trinchieri M., Perletti G., Magri V. Chronic prostatitis and related psychological problems. Which came first: The chicken or the egg? A systematic review. Arch Ital Urol Androl. 2023. Mar 20; 95(1): 11300. Doi: 10.4081/aiua.2023.11300. PMID: 36943000
11. Magistro G., Stief C. G., Wagenlehner F. M. E. Chronische prostatitis/chronisches beckenschmerzsyndrom [Chronic prostatitis/chronic pelvic pain syndrome]. Urologe A. 2020. Jun; 59(6): 739–748. German. Doi: 10.1007/s00120-020-01226-5. PMID: 32495006
12. Lam J. C., Stokes W. Acute and Chronic Prostatitis. Am Fam Physician. 2024. Jul; 110(1): 45–51. PMID: 39028781
13. Psychoneurological and sexological aspects in the book “Prostatitis”/ GS Vasilchenko, ST Agarkov. Journal of Neuropathology and Psychiatry named after S. S. Korsakov. 1990. No. 2. Pp. 150–152.
14. Zagorodny P. I. Sexual dysfunction in neuroses and reactive states in men. L., 1992. 45 p.
15. Cai T., Alidjanov J., Palagin I., Medina-Polo J., Nickel J. C., Wagenlehner F. M. E. Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): look to the future. Prostate Cancer Prostatic Dis. 2024. Jun;27(2):239-241. Doi: 10.1038/s41391-023-00645-7. Epub 2023. Jan 11. PMID: 36631538
16. Pendegast H. J., Leslie S. W., Rosario D. J. Chronic Prostatitis and Chronic Pelvic Pain Syndrome in Men. 2024. Jan 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Jan. PMID: 38261706
17. Preobrazhenskaya I. S., Zilov V. G. Asthenia and cognitive impairment in middle-aged patients: etiology, pathogenesis, approaches to therapy. Effective Pharmacotherapy. 2024; 20 (27): 28–36.
This work is licensed under a Creative Commons Attribution 4.0 License.